Cargando…
Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report
RATIONALE: Thrombotic microangiopathy (TMA) is a group of clinical syndromes characterized by excessive platelet activation and endothelial injury that leads to acute or chronic microvascular obliteration by intimal mucoid and fibrous thickening, with or without associated thrombi. It frequently inv...
Autores principales: | Cassol, Clarissa A., Williams, Michael P.A., Caza, Tiffany N., Rodriguez, Sophia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775360/ https://www.ncbi.nlm.nih.gov/pubmed/31574818 http://dx.doi.org/10.1097/MD.0000000000017148 |
Ejemplares similares
-
Clinical characteristics, triggering etiologies, and response of plasmapheresis in thrombotic microangiopathy in Taiwan
por: Chung, Ching-Hu, et al.
Publicado: (2021) -
Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study
por: Li, Qiu-Yu, et al.
Publicado: (2016) -
A rare case of malignant hypertension with splenic rupture and thrombotic microangiopathy: A case report
por: Ding, JiaXiang, et al.
Publicado: (2020) -
Decitabine-induced kidney thrombotic microangiopathy with glomerular crescents formation and tubular necrosis: A case report
por: Qin, Ai-bo, et al.
Publicado: (2020) -
Case report and literature review: Glomerular and neurologic thrombotic microangiopathy as a primary manifestation of multicentric castleman disease
por: Flahault, Adrien, et al.
Publicado: (2016)